CLINICAL_TRIALS
trial_result
· 2019-02-26
Clinical Trial Update: A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris [Phase 2]
Summary
Phase 2 dose-ranging study of DRM01 in acne vulgaris completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dermira, Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2019-02-26